Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-45,594
Closed -$1.51M 878
2024
Q1
$1.51M Sell
45,594
-42,042
-48% -$1.57M 0.01% 673
2023
Q4
$3.83M Buy
87,636
+36,667
+72% +$1.47M 0.04% 549
2023
Q3
$2.34M Sell
50,969
-242,559
-83% -$11M 0.02% 620
2023
Q2
$14.6M Buy
293,528
+8,940
+3% +$431K 0.14% 204
2023
Q1
$15.3M Buy
284,588
+99,230
+54% +$5.41M 0.15% 185
2022
Q4
$12.7M Sell
185,358
-193,243
-51% -$13M 0.13% 229
2022
Q3
$23.1M Sell
378,601
-125,040
-25% -$6.68M 0.26% 94
2022
Q2
$17.2M Buy
503,641
+103,000
+26% +$3.83M 0.18% 152
2022
Q1
$17.2M Buy
400,641
+116,240
+41% +$5.88M 0.15% 199
2021
Q4
$22.7M Sell
284,401
-196,592
-41% -$12.8M 0.17% 167
2021
Q3
$23.8M Buy
+480,993
New +$22.2M 0.18% 160
2014
Q1
Sell
-235,000
Closed -$2.27M 1419
2013
Q4
$2.27M Buy
+235,000
New +$2.51M 0.01% 1044

Other funds holding CALX

Royce & Associates's CALX Position: Q2 2024 in Review

Royce & Associates sold out of Calix (CALX) in Q2 2024, closing a stake of 45,594 shares — an estimated $1.51M sold.

Royce & Associates first reported a position in CALX in Q4 2013 and held it in 12 quarters. The position peaked at $23.8M in Q3 2021. 254 funds tracked by Wall St. Rank hold CALX as of Q2 2024.

  • Royce & Associates reported no remaining Calix position as of Q2 2024 after selling out during the quarter.
  • Royce & Associates sold 45,594 Calix shares in Q2 2024, an estimated $1.51M.
  • Royce & Associates first reported a position in Calix in Q4 2013 and held it in 12 quarters.
  • Royce & Associates's Calix position peaked at $23.8M in Q3 2021.
  • 254 funds tracked by Wall St. Rank held Calix as of Q2 2024.

Based on Royce & Associates's 13F filing for Q2 2024, filed 13 Aug 2024.